These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 4028622)
1. Pharmacokinetics of transdermally delivered clonidine. MacGregor TR; Matzek KM; Keirns JJ; van Wayjen RG; van den Ende A; van Tol RG Clin Pharmacol Ther; 1985 Sep; 38(3):278-84. PubMed ID: 4028622 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine. Arndts D; Arndts K Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of a new transdermal clonidine, M-5041T, in healthy subjects. Fujimura A; Ebihara A; Shiga T; Kumagai Y; Ohashi K; Nakashima H; Kotegawa T J Clin Pharmacol; 1993 Dec; 33(12):1192-200. PubMed ID: 8126254 [TBL] [Abstract][Full Text] [Related]
6. Influence of application site of a new transdermal clonidine, M-5041T, on its pharmacokinetics and pharmacodynamics in healthy subjects. Ebihara A; Fujimura A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T J Clin Pharmacol; 1993 Dec; 33(12):1188-91. PubMed ID: 8126253 [TBL] [Abstract][Full Text] [Related]
7. An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine. Harron DW; Arndts D; Finch M; Shanks RG Br J Clin Pharmacol; 1983 Oct; 16(4):451-5. PubMed ID: 6626441 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route. Shaw JE Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children. Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489 [TBL] [Abstract][Full Text] [Related]
12. New aspects of the clinical pharmacology of clonidine. Arndts D Chest; 1983 Feb; 83(2 Suppl):397-400. PubMed ID: 6822136 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects. Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335 [TBL] [Abstract][Full Text] [Related]
15. Proof of the linearity of the pharmacokinetics of alinidine in man. Arndts D; Warnkross H; Rominger KL; Justus H Eur J Clin Pharmacol; 1981; 21(3):201-7. PubMed ID: 7318879 [TBL] [Abstract][Full Text] [Related]
16. New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man. Arndts D; Doevendans J; Kirsten R; Heintz B Eur J Clin Pharmacol; 1983; 24(1):21-30. PubMed ID: 6832197 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic characterisation of transdermal delivery systems. Berner B; John VA Clin Pharmacokinet; 1994 Feb; 26(2):121-34. PubMed ID: 8162656 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients. Frisk-Holmberg M; Edlund PO; Paalzow L Br J Clin Pharmacol; 1978 Sep; 6(3):227-32. PubMed ID: 687501 [TBL] [Abstract][Full Text] [Related]
20. Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers. Lima DR; Santos RM; Werneck E; Andrade GN Eur J Drug Metab Pharmacokinet; 1991; 16(3):161-70. PubMed ID: 1814733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]